REATA PHARMACEUTICALS INC
REATA PHARMACEUTICALS INC (RETA) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 697 transactions totaling $343.3M, demonstrating a bearish sentiment with -$14.0M in net insider flow. The most recent transaction on Sep 26, 2023 involved a transaction of 24,089 shares valued at $0.
RETA Insider Activity Summary
Who Is Buying RETA Stock?
No significant insider buying has been recorded for RETA in the recent period.
Who Is Selling RETA Stock?
No significant insider selling has been recorded for RETA in the recent period.
Is REATA PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RETA is bearish with an Insider Alignment Score of 48/100 and a net flow of -$14.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
RETA Frequently Asked Questions
Understanding RETA Insider Activity
Insider trading at REATA PHARMACEUTICALS INC (RETA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading RETA stock, having executed 697 transactions in the past 90 days. The most active insider is Inc Cpmg (Executive), who has made 171 transactions totaling $47.6M.
Related Tools
Track REATA PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at RETA file new Form 4 transactions